U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748767) titled 'Micro-nanoplastic Exposure and Coronary Microcirculatory Dysfunction as Well as Cardiovascular Outcomes' on July 26.
Brief Summary: With strict quality control procedures applied throughout microplastic testing, this study will assess the association between baseline circulating micro-nanoplastic exposure and coronary microvascular dysfunction, as well as subsequent long-term cardiovascular outcomes.
Study Start Date: Jan. 01, 2027
Study Type: OBSERVATIONAL
Condition:
Coronary Microvascular Dysfunction (CMD)
Microplastic Exposure
Nanoplastics
MACE
Intervention:
OTHER: micro-nanoplastic examination
In this prospective cohort st...